Turning to the topic of affordability, Rascoff said prices rebounded quickly off the bottom and are currently up 6% year over year.
When asked about Zillow's revenue model, Rascoff explained that real estate shopping transitioned from offline to online, then from online to mobile. Advertisers follow the audience, he said, and Zillow offers 70 million people.
Rascoff defended Zillow's policy of not interfering with agent and lender reviews on its Web site, saying that Zillow's job is to empower the user and sometimes that means bad reviews get posted.
Executive Decision: Clay Siegall
In still another "Executive Decision" segment, Cramer sat down with Clay Siegall, chairman, president and CEO of Seattle Genetics (SGEN - Get Report), a stock that's up 110% since Cramer last spoke with Siegall in December 2012.
Siegall said that, first and foremost, Seattle Genetics is a drug company that helps cancer patients. However, his company also has a second part to its business that licenses its technology. Sales for 2013 totaled $250 million globally, he said, while license payments also brought in $250 million.Siegall said that while the company's primary cancer drug continues to sell well in 39 countries, Seattle Genetics also has other exciting drugs in testing -- two for lymphoma and another for breast cancer. Cramer said for investors not willing to take risks on hot biotech IPOs, Seattle Genetics is a great way to play the sector without all the risks.